| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cytomx Therapeutics, Inc. (CTMX) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. CTMX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 987.9K | $3.95M | - | |
| Other | 650.0K | $2.60M | - | |
| CFO | 78.3K | $313.0K | - | |
| Other | 43.8K | $175.0K | - | |
| Dir | 38.0K | $152.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20, 2023 | Belvin Marcia51 | SVP, Chief Scientific Officer | Sell | 4,077 | $1.38 | $5,628.30 | -2.6% | +62.7% | -17.9% | |
| Dec 20, 2023 | Landau Jeffrey B55 | Chief Business Officer | Sell | 4,077 | $1.38 | $5,628.30 | -4.5% | +62.7% | -17.9% | |
| Dec 20, 2023 | Rowland Lloyd A50 | General Counsel | Sell | 4,077 | $1.38 | $5,629.11 | -4.0% | +62.7% | -17.9% | |
| Dec 20, 2023 | Ogden Christopher52 | SVP, Finance And Accounting | Sell | 1,990 | $1.38 | $2,747.39 | -3.9% | +62.7% | -17.9% | |
| Sep 22, 2023 | Belvin Marcia51 | SVP, Chief Scientific Officer | Sell | 4,119 | $1.30 | $5,355.94 | -2.7% | +10.2% | -7.0% | |
| Sep 22, 2023 | Landau Jeffrey B55 | Chief Business Officer | Sell | 4,119 | $1.30 | $5,355.94 | -5.1% | +10.2% | -7.0% | |
| Sep 22, 2023 | McCarthy Sean A.69 | CEO | Sell | 14,601 | $1.30 | $18,987.14 | -3.3% | +10.2% | -7.0% | |
| Sep 22, 2023 | Rowland Lloyd A50 | General Counsel | Sell | 5,486 | $1.30 | $7,135.09 | -6.4% | +10.2% | -7.0% | |
| Mar 29, 2023 | Jones Elaine V | Director | Buy | 5,000 | $1.55 | $7,750.00 | +3,521% | -8.1% | +42.0% | |
| Mar 16, 2023 | Ogden Christopher52 | SVP, Finance And Accounting | Sell | 516 | $1.98 | $1,021.32 | -1.3% | -19.1% | +6.7% |